Loading...
Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
BACKGROUND: The rapidly expanding arsenal of chemotherapeutic agents approved in the past 5 years represents significant progress in the field. However, this poses a challenge for oncologists to choose which drug or combination of drugs is best for any individual. Because only a fraction of patients...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097425/ https://ncbi.nlm.nih.gov/pubmed/27814715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2886-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|